NCT02834390 2025-03-05Study of Quizartinib in Japanese Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)Daiichi SankyoPhase 1 Completed7 enrolled 16 charts
NCT01035502 2013-09-27A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid LeukaemiaClavis PharmaPhase 2 Completed51 enrolled